InMed Pharmaceuticals (FRA:MWG0) Total Stockholders Equity : €10.22 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is InMed Pharmaceuticals Total Stockholders Equity?

InMed Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €10.22 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. InMed Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2024 was €1.69. The ratio of a company's debt over equity can be used to measure how leveraged this company is. InMed Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.10.

InMed Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for InMed Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMed Pharmaceuticals Total Stockholders Equity Chart

InMed Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

12.29

5.22

6.12

8.59

11.16

InMed Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															11.57	11.16	8.98	11.71	10.22

InMed Pharmaceuticals (FRA:MWG0) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

InMed Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(10.217	-	0)	/	6.05897
	=	1.69

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

InMed Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.318	+	0.667)	/	10.217
	=	0.10

InMed Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of InMed Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

InMed Pharmaceuticals (FRA:MWG0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InMed Pharmaceuticals Inc (FRA:MWG0) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

INM:USA MWG0:Germany

Address

815 West Hastings Street, Suite 310, Vancouver, BC, CAN, V6C 1B4

Website

https://www.inmedpharma.com

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

InMed Pharmaceuticals (FRA:MWG0) Headlines

No Headlines